Friday, October 15, 2021

Stellantis: About 1,100 laid off Belvidere employees offered deals to relocate, quit or be fired

How much longer for Belvidere Auto Plant?????

Stellantis letter 3



  • BELVIDERE (WREX) — We now know how many laid off employees have received a letter offering them a chance to relocate to return to work full-time.

13 WREX first reported about laid off employees receiving the letters Thursday night.

Now, Stellantis says "about 1,100" employees received a letter. The manufacturer says they have full-time openings at its Toledo Assembly Complex and several Mopar locations.

Employees who were given these letters have three options: accept the offer and relocate, decline the placement or not respond to the letter.

If an employee declines the placement, they will be placed with no company-provided income or benefits, but will maintain their eligibility for other job opportunities.

Failure to respond to the letter at all would lead to termination.

13 WREX obtained the three letters the laid off employees were given. One of the letters requires the employee to respond with a decision by 3 p.m. Friday, Oct. 22.

Here's Stellantis' full statement:

Stellantis currently has full-time job openings at its Toledo Assembly Complex and several Mopar locations. As per the terms of the UAW-FCA collective bargaining agreement, indefinitely laid off employees can be offered full-time opportunities in other labor markets. As a result, the company sent letters on Oct. 8, 2021, to about 1,100 previously indefinitely laid off Belvidere employees offering them the opportunity to staff those positions and return to work. These employees can either accept or decline the placement. However, as stated in the contract, declining will place them with no company-provided income or benefits, but they will maintain their eligibility for other job opportunities. Laid off employees who fail to respond to the letter will be terminated. We understand this may be a difficult decision for a number of our employees and their families, but it is our goal to get as many people as possible back to full-time employment.

Above is from:  https://www.wrex.com/news/top-stories/stellantis-about-1-100-laid-off-belvidere-employees-offered-deals-to-relocate-quit-or-be/article_4c7f569e-2df1-11ec-8d1a-9bdae204c159.html

Thursday, October 14, 2021

October 14: Johns Hopkins COVID 19 Report

COVID-19 Situation Report

Editor: Alyson Browett, MPH

Contributors: Clint Haines, MS; Natasha Kaushal, MSPH; Amanda Kobokovich, MPH; Christina Potter, MSPH; Matthew Shearer, MPH; Marc Trotochaud, MSPH; and, Rachel A. Vahey, MHS.

EPI UPDATE The WHO COVID-19 Dashboard reports 238.5 million cumulative cases and 4.86 million deaths worldwide as of October 13. Global weekly incidence decreased by 6.7% compared to the previous week, and mortality fell by 9.5%.

Global Vaccination

The WHO reported 6.36 billion cumulative doses of SARS-CoV-2 vaccines administered globally as of October 10. A total of 3.63 billion individuals have received at least 1 dose, and 2.64 billion are fully vaccinated. Analysis from Our World in Data indicates that the overall trend in global daily vaccinations continues to decline, down to fewer than 23 million doses per day*. The global trend continues to closely follow Asia. Our World in Data estimates that there are 3.78 billion vaccinated individuals worldwide (1+ dose; 47.97% of the global population) and 2.80 billion who are fully vaccinated (35.56% of the global population).

*The average daily doses administered may exhibit a sharp decrease for the most recent data, particularly over the weekend, which indicates effects of reporting delays. In an effort to reflect the longer-term trends, the numbers reported here may not correspond to the most recent data.

UNITED STATES

The US CDC reports 44.5 million cumulative COVID-19 cases and 716,370 deaths. The US has passed a peak in terms of daily incidence. The most recent high was 161,711 new cases per day on September 1, and the trend began to decline slightly before the Labor Day holiday weekend. The current average is approximately 86,181 new cases per day and appears to be decreasing. Daily mortality also appears to have passed a peak, down from a recent high of 1,815 on September 15 to 1,252 on October 12*.

*Changes in state-level reporting may affect the accuracy of recently reported data, particularly over weekends. In an effort to reflect the longer-term trends, the numbers reported here may not correspond to the most recent dates.

According to an analysis published October 13 by the Peterson Center on Healthcare and the Kaiser Family Foundation, COVID-19 continues to be a leading cause of death in the US. While daily mortality is now falling, COVID-19 was the second leading cause of death in the US in September 2021, behind heart disease, according to the analysis based on US CDC and other data. The majority of COVID-19-related deaths have been among unvaccinated individuals.

US Vaccination

The US has administered 404 million cumulative doses of SARS-CoV-2 vaccines. The daily vaccination trend rose briefly following authorization of booster doses of the Pfizer-BioNTech vaccine for some populations on September 22 but is now declining after a recent peak on October 1*. There are 217.6 million individuals who have received at least 1 dose, equivalent to 65.6% of the entire US population. Among adults, 78.5% have received at least 1 dose, as well as 14.7 million adolescents aged 12-17 years. A total of 187.9 million individuals are fully vaccinated, which corresponds to 56.6% of the total population. Approximately 68% of adults are fully vaccinated, as well as 12.1 million adolescents aged 12-17 years.

*Due to delays in reporting, estimates for the average daily doses administered are less accurate for the most recent 5 days. The most current average provided here corresponds to 5 days ago.

VACCINE BOOSTERS The US FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) is meeting today to discuss Moderna’s request for authorization of an additional dose of its SARS-CoV-2 vaccine and on October 15 to discuss a similar request from J&J-Janssen. Any recommendations the committee makes are used to help the FDA make decisions but are not binding. Moderna has asked regulators to authorize an additional half-dose of its vaccine for adults aged 65 and older—a decision which appears to already be made based on questions submitted to the committee—and individuals at high risk of severe COVID-19, similar to the authorization granted last month for the Pfizer-BioNTech vaccine. An FDA briefing document released this week suggests that a booster dose of Moderna’s vaccine administered at least 6 months from the second dose increased antibody levels in recipients. However, the difference of the levels before and after the booster dose was not wide, and the agency did not take a position on whether the extra dose was necessary. The panel also will discuss the risk of post-vaccination myocarditis and other adverse reactions and whether data show efficacy of the Moderna vaccine is waning. In separate documents submitted to the FDA, Moderna said a half-dose (50μg) additional shot provided similar increases in antibody levels as the full dose (100μg) but with fewer side effects.

During the second day of meetings, VRBPAC will consider whether data presented by J&J-Janssen supports a booster dose for its single-dose SARS-CoV-2 vaccine, and when the additional dose should be administered. In a briefing document released October 13, the FDA said there “may be a benefit” in giving a second dose about 2 months after the primary dose and made it clear that while the J&J-Janssen vaccine provides protection against severe COVID-19, it is less effective than the mRNA vaccines from Moderna and Pfizer-BioNTech. However, the agency questioned the sample sizes of the studies showing a benefit and did not provide a clear conclusion on whether the panel would recommend booster doses for certain populations.

VRBPAC also likely will discuss “mixing and matching” vaccines but is not expected to make recommendations on the approach. Highly anticipated results from a US NIH-sponsored study were posted to the preprint server medRxiv on October 13, suggesting that recipients of the J&J-Janssen vaccine might produce a more intense immune response to a booster dose of an mRNA vaccine than an additional dose of the J&J-Janssen vaccine. Individuals who initially received either the Moderna or Pfizer-BioNTech vaccines and received a third dose of either shot showed similarly strong immune responses, according to the study, which is not yet peer-reviewed. The US CDC’s Advisory Committee on Immunization Practices (ACIP) is scheduled to meet next week to discuss the FDA’s recommendations on booster doses. If regulators eventually decide to permit mixing and matching vaccines, the FDA will have to amend the authorizations of both mRNA vaccines to permit them to be used to boost the J&J-Janssen vaccine.

US TRAVEL REQUIREMENTS The US plans to ease travel restrictions in November for fully vaccinated individuals crossing its land borders with Canada and Mexico, marking a reopening to travelers and tourists after being closed for more than 18 months. Unvaccinated individuals will continue to be banned from crossing the country’s northern and southern borders for nonessential travel. The new rules—which coincide with and are similar to recently updated guidance for air travelers—will be implemented in phases, with vaccinated visitors traveling for nonessential reasons to be allowed to cross land borders in November, and all inbound travelers, whether essential or nonessential, needing proof of vaccination by January 2022. Canada reopened its US border to nonessential travel by fully vaccinated US residents in August, and Mexico never closed its northern border. Several US Members of Congress representing border states welcomed the rule changes, as closures had separated cross-border families and wrought financial tolls on border cities. Notably, the US will keep in place a separate immigration policy that allows the government to deport or turn away any migrants who are seeking asylum or economic opportunity.

VACCINE MANDATES Since US President Joe Biden announced SARS-CoV-2 vaccination requirements for federal workers and contractors, healthcare systems, and employers with 100 or more employees, most workers have chosen to be vaccinated, despite some predictions mandates might worsen labor shortages by prompting widespread resignations. The requirements boosted vaccination rates by at least 20 percentage points, White House officials said on October 13. Aerospace company Boeing and Southwest Airlines are the latest large corporations to announce their employees must be vaccinated or receive exemptions by December 8, in compliance with new federal guidelines expected to be finalized soon. However, confusion arose for Texas-based Southwest and American Airlines, as well as other companies, on October 11, as Texas Governor Greg Abbott signed an executive order extending bans on COVID-19 vaccine mandates by any entity in the state, including private employers, and broadening reasons for exemptions. A previous executive order from Governor Abbott bans vaccine requirements by government agencies, cities, counties, and school districts in the state. Both Southwest and American indicated they will maintain their vaccine requirements for employees. Most other companies also likely will follow the federal rule, as federal law takes precedence over state law under the Supremacy Clause of the US Constitution. But questions over the conflicting laws remain.

In Florida, the state Department of Health levied a fine of more than US$3.5 million on Leon County for requiring county employees to be vaccinated, in violation of a state law. Under the law, government agencies can be fined US$5,000 for each violation of requiring vaccination as a condition of employment. The state said Leon County violated the law 714 times, for each of its employees, accruing a fine of US$3.57 million it must pay within 30 days. The Leon County administrator called the ban politically motivated and vowed to enforce the county vaccine mandate “using any remedies available.”

In New York, a federal judge on October 12 issued a preliminary injunction barring state health officials from interfering with employers who allow religious exemptions to state-imposed vaccination mandates for all healthcare workers. Judge David N. Hurd of the Northern District said the state overreached by barring all religious accommodations in its mandate and wrote that the 17 healthcare workers who filed the lawsuit were likely to succeed. New York Governor Kathy M. Hochul vowed to appeal the ruling. The case (Dr. A et al v. Hochul) provides a test for strict vaccine mandates covering healthcare workers. At least 23 states require SARS-CoV-2 vaccination for healthcare workers.

SARS-COV-2 ORIGIN The WHO on October 13 announced 26 proposed members of its new Scientific Advisory Group for the Origins of Novel Pathogens (SAGO), which is tasked with creating a global framework to define and guide investigations into the origins of emerging and re-emerging diseases of epidemic and pandemic potential, including SARS-CoV-2. The scientists, hailing from 26 different nations, have expertise in a wide range of areas, from molecular biology to animal health and include 6 members of the previous 10-person joint WHO-China mission that investigated the COVID-19 pandemic’s origins and issued inconclusive findings more than 6 months ago. The WHO said the renewed effort might be the “last chance” to find the virus’s origins, but some questioned whether an advisory board will have the power to make inroads with China, which has not been a very cooperative partner. This week, Chinese officials said the country plans to test up to 200,000 blood bank samples from the city of Wuhan, where the virus was first identified in December 2019. The samples have been in storage for 2 years and could help provide clues as to when and where the virus first appeared in humans.

In an editorial published the same day in Science, WHO leadership encouraged that all origin possibilities be investigated, including the so-called “lab-leak theory” that the virus inadvertently escaped a laboratory in Wuhan. Notably, the previous WHO investigation deemed that theory “very unlikely.” Chinese officials continue to encourage researchers to look in other countries for clues but have said they will work within the framework of SAGO. The WHO plans to finalize the SAGO members following a 2-week public consultation period. Although the window of opportunity for finding the origins of the current pandemic is closing, and many questions remain unanswered, learning more about the origins of SARS-CoV-2 could help prevent the next outbreak.

FLU SEASON Medical professionals and public health experts worldwide are urging everyone to receive their flu vaccine in advance of what could be a particularly severe flu season this coming winter. Last year, SARS-CoV-2 appeared to displace most of the circulating seasonal influenza viruses with 1 pediatric flu death in the US for 2020 compared to 75-150 pediatric deaths in previous seasons. This year, experts are warning of a “twindemic” of COVID-19 and flu cases, as pandemic restrictions are easing. Since there were relatively few cases of flu last year, experts worry that immunity against the flu will be lower in the general population this year, potentially resulting in more cases and hospitalizations. Unlike with SARS-CoV-2 vaccines, flu vaccines are approved for children 6 months and older. Combined with effective respiratory disease control measures, such as masking and physical distancing, it is doubly important this year to obtain a flu vaccine. A recent study published in PLoS One suggested that flu shots could have protective effects against COVID-19 severe outcomes. In a retrospective cohort of more than 74,000 patients hospitalized with COVID-19, those who had received a flu vaccine had significantly lower risks of sepsis, stroke, and subsequent emergency department visits for COVID-19-related outcomes. More studies are needed to further examine this possible correlation, but the results are encouraging to solidify the case for all eligible persons to get their flu vaccine.

CUREVAC CureVac announced October 12 that it is withdrawing its first-generation SARS-CoV-2 mRNA vaccine candidate, CVnCoV, from the current approval process with the European Medicines Agency (EMA) to instead focus on developing second-generation mRNA vaccine candidates in collaboration with GlaxoSmithKline (GSK). The company also terminated an advance agreement with the European Commission (EC) for the sale of 405 million doses of the vaccine after approval. The announcement represents the seventh vaccine candidate to be abandoned after clinical trials, in part due to the success of mRNA vaccines from Pfizer-BioNTech and Moderna.

ABUSE OF SCIENTISTS A self-selecting survey by Nature of more than 300 scientists who have spoken publicly about COVID-19 in media interviews or on social media found 15% said they had received death threats, with nearly 60% of those surveyed saying they had faced other forms of harassment or abuse. Notably, most researchers said their experiences with media interviews were positive but those who reported the highest frequency of personal attacks or trolling were also the most likely to indicate a reduced willingness to speak with the media in the future. Nature predicts that these results could have a “chilling effect” on science communication.

Vaccine Nationalism

Yahoo News

Countries decry 'vaccine nationalism' as poorer nations struggle for access to shots

Marquise Francis

Marquise Francis

·National Reporter & Producer

Wed, October 13, 2021, 4:32 PM

Seventy-five countries around the world called for an end to what they describe as “vaccine nationalism” in a joint letter to the United Nations this month.

The letter, spearheaded by China, demands that COVID-19 vaccines be treated as a global public good for health, arguing that richer countries should not be allowed to stockpile their resources while poorer countries go without.

“The pandemic knows no borders,” the letter says in part. “The only solution lies in global solidarity, unity and multilateral cooperation. ... At this critical time, it is crucial to step up our joint efforts to leave no one behind.”

The concept of vaccine nationalism refers to the signed agreements a number of countries made with the vaccine manufacturers before the shots became available to the general public, allowing them to buy up large amounts, which in turn makes the initial supply of vaccines unaffordable and inaccessible to poorer countries.

Zhang Jun L, China's permanent representative to the United Nations, delivers a speech on behalf of 75 countries to the General Debate of the Third Committee of the UN General Assembly at the UN headquarters in New York, Oct. 1, 2021. (Photo by Wang Ying/Xinhua via Getty Images)

Zhang Jun, China's permanent representative to the United Nations, speaking at the U.N. General Assembly on Oct. 1. (Wang Ying/Xinhua via Getty Images)

More than 18 months into the pandemic, while some wealthy nations appear headed toward pre-pandemic normals, many cash-strapped countries remain ravaged for resources.

Mexico, Egypt and North Korea were among the countries that signed the joint letter. Noticeably absent were the U.S., the U.K. and Canada.

The letter outlines deep concerns regarding a lack of vaccine equity for poorer countries, which, it argues, only exacerbates already prevalent issues of poverty and hunger, trade and more.

Sixty-five percent of the population of high-income countries had received at least one vaccine shot as of Sept. 9, while just 2 percent of the population of low-income countries had received at least one dose, according to data from the Kaiser Family Foundation.

This summer the European Union secured 900 million doses of Pfizer’s vaccine and reserved an option to double this amount by 2023. Even without exercising that option, the EU could give all its citizens at least six shots each. The U.S. has secured more than a billion shots, enough to inoculate every American at least five times. Meanwhile, residents of many smaller and poorer nations have yet to receive a single dose.

Vaccination rates in countries like Haiti and the Democratic Republic of the Congo remain less than 1 percent, according to Reuters tracking data.

A medical worker administers a dose of COVID-19 vaccine for a man in Goma, northeast Democratic Republic of the Congo DRC, on Oct. 8, 2021. (Photo by Zanem/Xinhua via Getty Images)

A medical worker administers a dose of COVID-19 vaccine for a man in Goma, Democratic Republic of the Congo, on Oct. 8. (Zanem/Xinhua via Getty Images)

The disparity in vaccination rates also comes with a hefty price tag. A National Bureau of Economic Research study determined that uneven distribution of the vaccine could cost upwards of $3.8 trillion globally, while vaccinating the world’s most vulnerable fifth of the population would cost less than $40 billion.

Aaditya Mattoo, World Bank chief economist for the East Asia and Pacific region, expressed disappointment in the current rollout.

"I am a trade economist and all my life, I believed that production should happen where it is most efficient and then be distributed to where there is greatest need," Mattoo told the Manila Times last week. "But this crisis has disappointed me because instead of countries pursuing a globally optimal cooperative strategy, there has been what we call vaccine nationalism.”

Poor and middle-class countries have accrued enough vaccines through 2023 to vaccinate at most half their populations, while the majority of rich countries have secured more than 350 percent of the doses needed for their populations, according to UNICEF data.

Worldwide access has faltered, but attempts have been made to fill the gap. Smaller countries that depend on the COVID-19 Vaccines Global Access, or COVAX — an international initiative seeking to ensure equitable access to vaccines — have made little progress.

COVAX was formed in April 2020 as a way for high-income countries and corporations to pay for vaccine access to the 92 poorest countries. The program initially appeared to run smoothly as vaccine distributions began in late February, with almost every country in the world signing up. But as the months went on, supply chains slowed and COVAX could not financially compete with richer countries that were buying up market share.

An analysis by Global Justice Now revealed that more than 82 percent of COVID-19 vaccines have been purchased by the wealthiest countries, accounting for just 14 percent of the world population. The long-term effects of this could be dire.

A member of the public receives a Pfizer Covid vaccination at an NHS walk-up vaccination unit outside the village hall on September 25, 2021 in the village of Summercourt, near Newquay, Cornwall, United Kingdom. (Photo by Hugh Hastings/Getty Images)

A man receives a COVID-19 vaccination in the village of Summercourt, England, on Sept. 25. (Hugh Hastings/Getty Images)

Infectious disease expert Dr. Adeeba Kamarulzaman of Malaysia says the longer people remain unvaccinated, the more potential there is for the virus to mutate into an even more dangerous strain.

“I hope the world doesn’t live to regret the nationalism that we are practicing,” Kamarulzaman said during a webinar last week.

A Princeton University and McGill University study published in August in the journal Science also revealed that vaccine nationalism likely has a direct correlation to the transmission of the virus.

“Unequal vaccine allocation will result in sustained transmission and increased case numbers in regions with low vaccine availability and thus to a higher associated clinical burden compared with a vaccinated population,” the study found in part. “Coordinated vaccination campaigns across the world, combined with improved surveillance and appropriate nonpharmaceutical interventions to prevent case importation, are imperative.”

Leaders from several developing countries in attendance at the United Nations General Assembly last month criticized wealthy countries for enabling COVID variants to emerge because of their selfishness.

“Rich countries hoard lifesaving vaccines, while poor nations wait for trickles,” Philippine President Rodrigo Duterte said at the conference. “They now talk of booster shots, while developing countries consider half doses just to get by. This is shocking beyond belief and must be condemned for what it is — a selfish act that can neither be justified rationally nor morally.”

U.N. Secretary-General António Guterres lambasted the entire world on vaccine inequity, calling it an “obscenity” and saying, “We are getting an F in ethics.”

United Nations Secretary-General Antonio Guterres addresses the 76th Session of the U.N. General Assembly at UN Headquarters on September 21, 2021 in New York City. (Photo by Eduardo Munoz-Pool/Getty Images)

U.N. Secretary-General António Guterres addresses the General Assembly on Sept. 21. (Eduardo Munoz-Pool/Getty Images)

The World Health Organization has set an ambitious goal to have 40 percent of the world vaccinated by the end of the year and 70 percent by the middle of 2022. As of Wednesday afternoon, more than 3.75 billion people worldwide have received a dose of vaccine, accounting for just under 49 percent of the global population, according to the New York Times tracker. But more than 50 countries missed the WHO’s September target of 10 percent, with most of them located in Africa, whose overall vaccination rate remains under 5 percent.

Ghanaian President Nana Akufo-Addo told the U.N. General Assembly last month that Africa is the continent hardest hit by vaccine nationalism — 900 million Africans need to get the vaccine in order for the continent to reach the 70 percent threshold, with very little help in sight.

President Biden has called this moment an “all-hands-on-deck crisis,” pushing for all countries to reach a 70 percent vaccination rate by the fall of 2022. To do its part, the U.S. last month pledged to buy more than 500 million vaccine doses for other countries, which will bring the total number of donations promised by the U.S. to more than 1 billion.

"We're not going to solve this crisis with half-measures or middle-of-the-road ambitions. We need to go big," Biden said at a virtual summit on the pandemic last month.

But as many rich nations administer booster shots to the elderly and immunocompromised, many critics question if the U.S. is doing enough to encourage equity on the world stage.

“The more people that are vaccinated, the less likely new variants will evolve,” Avery August, a Cornell University immunologist, told Yahoo News. “However, all of these examples highlight the crucial lack of access lower-income countries have to the most cutting-edge medicines and vaccines. If these countries do not have the financial resources, or the scientific infrastructure, to participate in the development of these vaccines, they tend to be left out of the benefits, or at the very least are the last in line to receive the benefits.”

Pfizer's Covid-19 vaccine is pictured at Rady Children's Hospital before it's placed back in the refrigerator in San Diego, California on December 15, 2020. (Photo by ARIANA DREHSLER/AFP via Getty Images)

Bottles of Pfizer's COVID-19 vaccine. (Ariana Drehsler/AFP via Getty Images)

While many poorer countries push for access to vaccines, richer countries continue to vaccinate thousands each day.

More than 216 million Americans, or 65 percent of the U.S. population, have had at least one dose of a vaccine, according to data from the Centers for Disease Control and Prevention. Just over 56 percent of the country is fully vaccinated. Similarly, in Canada, 71 percent of the population has been inoculated at least once.

While critics fault countries like the U.S. and the U.K. for stockpiling resources, others say a collective approach needs to take place to help those in need.

Dr. Leana Wen, an emergency physician and a public health professor at George Washington University, told Yahoo News it’s a “false choice” to argue that the U.S. should stop giving out booster shots in order to help other countries.

“We need to scale up the manufacturing of doses around the world,” Wen said. “We need to be working with other entities to increase distribution systems for lower-income countries. But at the same time, we cannot deny Americans, including American children, including American adults, the ability to get an additional layer of protection.”

Cover thumbnail photo illustration: Yahoo News; photos: Getty Images, Ronny Hartmann/AFP via Getty Images

Above is from:  https://www.yahoo.com/news/countries-decry-vaccine-nationalism-as-poorer-nations-struggle-for-access-to-shots-213220083.html

“You are a Loser”

HuffPost

Republican Group Trolls Trump With Massive Billboard Reminding Him He's A Loser

  • Image

Ed Mazza

Thu, October 14, 2021, 3:52 AM


A Republican group is using billboards to send a blunt message to Donald Trump and his supporters who are still pushing for election audits based on debunked claims of election fraud.

“TRUMP LOST,” the billboards from Republicans for Voting Rights read. “NO MORE ‘AUDITS.’”

One billboard is in Times Square in New York: 

The group said it plans to put up dozens of billboards in eight states, many near state capitol buildings and in locations where Trump supporters are pushing for audits, including Georgia, Florida, Texas, Pennsylvania, Arizona and Michigan.

None of Trump’s wild claims of election fraud have been backed by evidence. A Republican-led audit in Maricopa County, Arizona, recently confirmed that Biden won there.

While the partisan audit was funded in part by Trump supporters, taxpayers in Maricopa County are now on the hook for nearly $3 million to replace equipment compromised by unprofessional auditors hired by Republicans in the state Senate.

In addition, the AP reported that Wisconsin’s Republicans have authorized $680,000 in taxpayer money for their own audit. GOP-backed efforts in Texas, New Hampshire and Pennsylvania could also leave taxpayers footing bills. 

“The 2020 election was secure and fair,” Amanda Carpenter, director of Republicans for Voting Rights, said in a statement. “These sham audits are a waste of time and money.”

The organization is part of of the Republican Accountability Project, which has been calling out GOP lawmakers who enabled Trump and supported the Jan. 6 insurrection.

This article originally appeared on HuffPost and has been updated.

Above is fromhttps://www.yahoo.com/news/republican-group-trolls-trump-massive-085227836.html

Tuesday, October 12, 2021

Federal Tax Revenue Increase in 2021


TAX

U.S. sees biggest revenue surge in 44 years despite pandemic

Revenues jumped 18 percent in the fiscal year that just ended, analysts say — the biggest one-year increase since 1977.

The Treasury Department building is shown.

The Treasury Department is set to release this week its final budget numbers for the fiscal year that ended Sept. 30. | Chip Somodevilla/Getty Images

By BRIAN FALER

10/12/2021 12:14 PM EDT

Despite a pandemic, a recession and a slew of tax cuts, federal tax receipts are booming.

Revenues jumped 18 percent in the fiscal year that just ended, analysts say — the biggest one-year increase since 1977.

That translates into $627 billion more than in 2020, according to the nonpartisan Congressional Budget Office, which estimates that, for the first time, total government revenues topped $4 trillion.

“They are just booming,” said Mark Booth, a former top revenue forecaster at the agency. “It is very unusual.”

Though Democrats are hammering the rich for not paying their fair share in taxes, the increase is being driven by levies primarily paid by the well-to-do. For example, corporate tax receipts leapt 75 percent, CBO says. At $370 billion, they easily top where they were immediately before Republicans slashed the corporate rate as part of the Tax Cuts and Jobs Act.

The surge has gotten relatively little notice, obscured perhaps by the government’s towering budget deficits and congressional battles over taxes and spending.

It is highly unusual, though, for the government to see a big wave of revenue in the wake of an economic downturn. Typically, receipts crash following recessions because, as people’s incomes fall, they owe less to the Treasury.

The coronavirus downturn was much more bifurcated, however, with higher-income people, who pay most federal taxes, doing far better than low earners.

“Usually revenues get hit hard in the year after a recession,” said Booth. “This time it is the opposite.”

The Treasury Department is set to release this week its final budget numbers for the fiscal year that ended Sept. 30. Those are expected to closely track estimates CBO published Friday.


The increases came across all major categories of taxes, according to CBO, with corporate receipts seeing the biggest jump, thanks to better-than-expected profits.

Payments by big companies had plunged in the wake of Republicans’ 2017 tax cuts, falling by almost a third to $205 billion the following year. They didn’t really begin to bounce back until this past fiscal year and then recovered to an extent that surprised analysts.

CBO repeatedly revised upward its estimates, and still came in too low. At $370 billion, the corporate tax haul would be the biggest, at least in nominal terms, since 2007.

Another big increase — 33 percent — came with “non-withheld” receipts, which include a variety of taxes that are not subject to withholding by employers.

CBO did not provide a breakdown of those levies. But big changes there are usually driven by capital gains realizations and payments by unincorporated businesses. And the agency previously upped its estimates of capital gains taxes over the past year.

Individual income taxes were up 27.5 percent, CBO estimates. Those too are disproportionately paid by the well-to-do, with 80 percent coming from the top 10 percent of earners.

The increases came despite lawmakers approving a series of tax cuts in the wake of the pandemic. At the time, they were projected to cost nearly $500 billion in 2021 — which would make them bigger than the first year’s worth of tax cuts included in Republicans’ 2017 legislation.

But some of the pandemic-related tax cuts, such as an employee retention credit meant to help keep workers on the payroll, were less popular than lawmakers anticipated — just because Congress cuts takes doesn’t mean everyone necessarily takes advantage of them.

The overall revenue increase wasn't only an anomaly compared to 2020, when receipts fell by just 1.2 percent to $3.420 trillion. Revenues in 2021 still rose 17 percent even when compared to 2019 levels, before the pandemic hit.

Receipts are volatile, but double-digit annual increases are uncommon — there have only been 11 such instances since 1977.

In July, CBO predicted receipts in 2022 would amount to 18.1 percent of GDP, the most in 20 years. Now it seems like the agency will have to revise that too upwards.

Above is fromhttps://www.politico.com/news/2021/10/12/tax-revenue-surge-pandemic-515792?cid=apn

VA Nursing Home in Danville did not use proper COVID guidelines

USA TODAY

Illinois VA nursing home didn't follow federal guidelines to contain COVID-19. 11 residents died.

Donovan Slack, USA TODAY

Tue, October 12, 2021, 11:07 AM

Leaders and staff at a federal veterans’ nursing home in Illinois mismanaged a coronavirus outbreak that killed 11 residents in fall 2020, well after employees had been put on notice about the danger the pandemic posed to its elderly population, a government investigation found.

A staff member exposed at home was denied a test and told to just wear a mask while finishing a shift caring for residents. The employee tested positive the next day.

Testing was inconsistent, even after the virus started to spread within the Veterans Affairs complex in Danville, in a rural part of the state near the Indiana border. Isolation of exposed individuals – even those who tested positive – was haphazard.

“Direct care staff described chaos and a lack of awareness of what to do,” the inspector general at the U.S. Department of Veterans Affairs concluded in a report released last month.

The outbreak lasted for five weeks in October and November 2020. During those two months, 92 staff and 239 patients tested positive at the facility, which includes a nursing home, hospital and outpatient clinic.

Marine Corps veteran Mike Manning, 73, was one of those who died, but his daughter said VA officials didn't cite the virus on his death certificate until she called to complain.

Marine Corps veteran Mike Manning, 73, died of COVID-19 on Nov. 17, 2020, during an outbreak at the Veterans Affairs nursing home in Danville, Ill.

Marine Corps veteran Mike Manning, 73, died of COVID-19 on Nov. 17, 2020, during an outbreak at the Veterans Affairs nursing home in Danville, Ill.

Caitlin Darling told USA TODAY she believes the staff who cared for her father did their best, but management may have left them ill-equipped to handle the outbreak.

"I don't know how many guys they ended up losing in my dad's ward," she said, "but I think last time I asked about it, it was eight out of 18, 10 out of 18."

Nursing homes were hot spots for coronavirus

COVID-19 tore through long-term care facilities across the country, accounting for a third of coronavirus deaths during the first year of the pandemic. Tragic tales of deaths due to problems with testing, personal protective equipment and infection control emerged at state veterans’ homes in Massachusetts, New Jersey and Texas.

The inspector general’s report on the VA Illiana Health Care System in Danville is the first to publicly detail extensive breakdowns at a facility operated by the U.S. Department of Veterans Affairs. The agency runs a system of 134 nursing homes that serve roughly 9,000 veterans a day across 46 states, the District of Columbia and Puerto Rico.

An examination by the Government Accountability Office in June found there were 3,944 cases and 327 deaths among residents of VA nursing homes from March 2020 through mid-February. The cumulative case rate among residents was 17%, and the death rate was 1%.

Those numbers are a fraction of the toll in nursing homes nationwide: In a study published by the JAMA Network, researchers estimate there were 592,629 cases and 118,335 deaths last year. The death rate among long-term care residents as of March was 8%, according to the COVID Tracking Project.

A nursing home resident is wheeled on a stretcher from an ambulance into the Canterbury Rehabilitation and Healthcare Center on April 14, 2020. At the time, the nursing home was one of the worst clusters of fatalities from COVID-19 in the country, with 42 deaths.

A nursing home resident is wheeled on a stretcher from an ambulance into the Canterbury Rehabilitation and Healthcare Center on April 14, 2020. At the time, the nursing home was one of the worst clusters of fatalities from COVID-19 in the country, with 42 deaths.

Deaths and infections at VA nursing homes varied, like they did at nursing homes overall. The highest cumulative case rates from March 2020 to mid-February ranged from 38% of residents at the VA nursing home in Los Angeles to 59% at the facility in Montrose, New York.

The highest death rates were at facilities in the Northeast, where they peaked at 8% to 12% during the early months of the pandemic.

The facility in Danville had the fifth-highest death rate – from zero to 6% in a month. The true rate is probably higher. After the GAO counted seven deaths during the outbreak, the inspector general found four other deaths related to COVID-19.

The watchdog launched an investigation after receiving complaints in October 2020 as the outbreak unfolded. Investigators concluded a lack of planning and urgency contributed to failures in testing, training and other infection-control measures.

The facility didn’t provide enough respiratory protection and training for nursing staff and defied a national directive by continuing group therapy sessions, investigators found.

A resident with confirmed COVID-19 was left overnight with a roommate, they found. The roommate wandered the halls and into communal areas before testing positive for the coronavirus.

Officials at the Department of Veterans Affairs in Washington issued a statement that they "deeply regret" coronavirus deaths at an Illinois facility.

Officials at the Department of Veterans Affairs in Washington issued a statement that they "deeply regret" coronavirus deaths at an Illinois facility.

VA officials extended condolences to loved ones of the veterans who died. In a statement provided to USA TODAY on Friday, VA officials in Washington said they "deeply regret" what happened.

Staci Williams, acting director of the Danville VA facility since August, said, “The cases in our Community Living Center (nursing home) impacted our entire staff and reinforced our commitment to learning and improving from the experience.”

Inadequate planning and a lack of urgency

The Danville VA facility, about 90 minutes west of Indianapolis, has primary care and mental health clinics and an acute care medical center with 38 hospital and psychiatric inpatient beds. The facility’s nursing home has more than 100 beds spread across several units, which provide rehabilitation services and long-term care for Alzheimer’s, dementia and other ailments.

When the virus hit last year, administrators developed a 46-item action plan covering everything from staff and visitor screening to signage and personal protective equipment. The facility set up a command center staffed with specialists in infection, quality control and emergency management. The director held town halls with staff. They planned to take coronavirus patients from the community if the need arose.

The inspector general found several critical breakdowns. The action plan included only two items specific to the nursing home – one about providing staff and space for training and another about screening people who entered.

By late June, after the rural area around Danville escaped the waves of infections reported in the Northeast and other urban areas, the director of the VA facility reduced the frequency of town hall meetings and curtailed operations at the command center.

Staff in nursing home units were not included in the facility’s respiratory protection program, so they weren’t all fit-tested and issued N95 masks or trained on the use of other respirators.

Though staff had planned what to do with patients from outside the facility, the inspector general found, “the Facility Director acknowledged that an internal outbreak was not part of the considerations.”

Staff with COVID-19 continued working, untested

The facility was ill-prepared Oct. 12, 2020, when a staffer in a nursing home unit developed a cough and learned that a close family member had tested positive.

Managers told investigators that an associate director told them the employee should work the remaining six hours of a shift. The associate director denied being consulted.

The staff member wasn’t tested and was told to put on a mask and keep working.

“This failure resulted in an employee, who later tested positive for COVID-19, providing direct patient care,” the inspector general found.

Under national VA guidance, after an employee tests positive, all staff and residents should be tested as soon as possible. The inspector general found two-thirds of staff in one Danville nursing home ward, nicknamed “Victory,” and 22% of staff in another, nicknamed “Unity,” were tested on their next shift.

“Three Victory and two Unity staff worked multiple shifts between October 13-19, 2020, before testing occurred and ultimately tested positive,” the inspector general reported.

The Soldiers' Home in Chelsea, Mass., is one of the state-run veterans’ facilities in Massachusetts, New Jersey and Texas that were hit hard in the early days of the pandemic. The VA provided assistance to the Chelsea and Holyoke Soldiers' Homes.

The Soldiers' Home in Chelsea, Mass., is one of the state-run veterans’ facilities in Massachusetts, New Jersey and Texas that were hit hard in the early days of the pandemic. The VA provided assistance to the Chelsea and Holyoke Soldiers' Homes.

Investigators found that staff treated two residents with aerosol-generating equipment such as nebulizers without precautions to contain the droplets. The two residents tested positive.

Group therapy sessions continued. In the days after the initial staff member’s diagnosis, five residents were diagnosed with COVID-19 shortly after attending group sessions with several residents. Before the outbreak, staff said, residents did not wear masks to the sessions, though the facilitator did.

A nursing home manager and recreation therapists told investigators they didn’t know about the directive to cancel group activities.

“Recreation therapists described their concern for both the physical and emotional well-being of the CLC (nursing home) residents and shared they wanted to do the best they could with the information that they had,” the inspector general said.

Resident quarantined, infected

Mike Manning had been at the Danville VA nursing home since January 2020, his daughter said.

Diagnosed with Parkinson’s disease and dementia, he had deteriorated in a matter of months, from driving, living alone and hanging out in a coffee shop in Springfield, Illinois, to needing the kind of care provided at the VA’s skilled nursing facility in Danville.

"He was not happy," Darling said. "Part of what kept him there and made him stop fighting me was COVID happened. And I said, Dad, you need to stay there where you're gonna be safe."

U.S. Bank in Springfield, Ill., displays five of Mike Manning's paintings of the area in its lobby.

U.S. Bank in Springfield, Ill., displays five of Mike Manning's paintings of the area in its lobby.

In late September, as part of pandemic safety protocols, Manning was quarantined in a room on the Victory ward for 14 days after having a medical test outside the facility, his daughter said. When he got out, he tested negative and was "out and about" on the ward and engaged in programming and his favorite pastime, painting. Within weeks, he was infected and had full-blown, double-lung pneumonia.

“I was a little astounded,” she said.

She said nursing staff told her a couple of other people on the ward had tested positive.

Isolation failures, delays

The inspector general's report, which does not identify veterans by name, detailed incidents when veterans who had tested positive were allowed to remain on their wards.

Shortly after 9 p.m. Oct. 20, a lab notified a doctor that two residents had COVID-19.

One of the veterans had a roommate who was known to wander the halls, and a nurse voiced concerns about leaving the infected veteran in the same room. A doctor decided not to move anyone that night since the roommate had already been exposed.

The infected residents were scheduled to be transferred to a quarantined COVID-19 unit the next morning. That didn’t happen until that evening – 20 hours after the lab results came in.

Staff said that during the ensuing hours, there was confusion about who was supposed to care for infected residents and which isolation protocols to follow.

The exposed roommate paced the ward, “including communal areas where other residents were congregated.”

It was about this time, between Oct. 20 and 22, that facility leaders met to discuss what to do about the outbreak. A plan was finalized Oct. 22 – seven months into the pandemic.

The outbreak continued until Nov. 17, when the last infected resident died.

Manning's daughter said she was allowed to visit him a few days before he died.

"When I went to pick up his stuff, the charge nurse, the other nurses that came out to bring his stuff out, were all sobbing – I mean, they are so heartbroken,” Darling said.

She donated a piece of his artwork to the facility, a painting of Abraham Lincoln, whose words became the motto of the VA: "to care for him who shall have borne the battle and for his widow, and his orphan.”

“Because they're the federal government, they can just go, ‘Oops,’” Darling said. “I don’t want their condolences. I want my dad.”

When investigators conducted a surprise visit in February, they found two employees on a quarantined COVID-19 unit not wearing masks properly. The facility director told investigators he was concerned about the facility’s culture and a lack of accountability on the wards. He has since left the VA.

The acting director pledged to have fixes in place by the end of March.

“As health care professionals, we find it difficult to accept the loss," Williams wrote in response to the findings, "especially as our staff were heavily invested in providing quality care and maintaining patient and staff safety throughout this pandemic.”

Contributing: Jayme Fraser

This article originally appeared on USA TODAY: COVID-19 outbreak mismanaged at VA nursing home, kills 11 residents

Above is from:  https://www.yahoo.com/news/va-nursing-home-illinois-didnt-090013283.html

October 12: Johns Hopkins COVID 19 Report

COVID-19 Situation Report

Editor: Alyson Browett, MPH

Contributors: Clint Haines, MS; Natasha Kaushal, MSPH; Amanda Kobokovich, MPH; Christina Potter, MSPH; Matthew Shearer, MPH; Marc Trotochaud, MSPH; and, Rachel A. Vahey, MHS.

WEBINAR: Please join the Johns Hopkins Center for Health Security for a webinar, Lessons from eMed: COVID-19 At Home Testing and Verifying the Results, on October 19, 2021 at 10am ET. We will discuss the ongoing importance of COVID-19 testing and the verification of testing results at-home. Please register here.

EXTENDED PRIMARY VACCINE SERIES On October 11, the WHO’s Strategic Advisory Group of Experts (SAGE) on Immunization recommended additional doses of SARS-CoV-2 vaccines for immunocompromised individuals. The recommendation applies to all 7 vaccines that have received an Emergency Use Listing (EUL) from the WHO and to all individuals who are moderately or severely immunocompromised individuals. SAGE also recommended a third dose of the Sinopharm and Sinovac vaccines for individuals aged 60 years and older. The advisory group emphasized that countries should initially prioritize administering the full original vaccine regimen to increase vaccination coverage, but an additional dose would provide extra protection for individuals at the highest risk for severe disease.

Notably, SAGE clearly distinguished its updated guidance from booster dose policies being implemented in some countries, including several in Europe, Israel, and the US. Specifically, the additional doses recommended under the new SAGE guidance are intended “as part of an extended primary series since [immunocompromised] individuals are less likely to respond adequately to vaccination” rather than as a general boost to protection for otherwise healthy individuals. The SAGE experts met for 4 days to discuss myriad vaccine-related issues, including non-pandemic topics such as the world’s first malaria vaccine, and the full meeting report is expected to be published in December. Reportedly, SAGE will address waning immunity and the need for broader booster doses in healthy individuals at a meeting scheduled for November 11.

MOLNUPIRAVIR EUA REQUEST Merck and Ridgeback Biotherapeutics on October 11 submitted an application with the US FDA for Emergency Use Authorization (EUA) of molnupiravir, an investigation oral antiviral medication, for the treatment of mild-to-moderate COVID-19 in adults at high risk of severe disease. Notably, if authorized by the FDA, the drug would be the first COVID-19 treatment to be administered orally, as all other authorized or approved medications are delivered intravenously or via injection. The companies’ submission is based on a Phase 3 clinical trial interim analysis showing molnupiravir reduced the risk of hospitalization or death by about half when compared with people who received a placebo. The data are not yet published or peer-reviewed. An effective therapeutic that is taken by people recovering at home could relieve some pressure on hospitals, particularly in areas with low vaccination rates.

Two Indian generic drug manufacturers last week requested permission to end late-stage clinical trials of generic versions of molnupiravir, after the drug did not show “significant efficacy” among people with moderate COVID-19 disease. A Merck spokesperson noted that the Indian studies defined moderate disease differently than the FDA and included patients with more severe disease. The Indian companies are continuing to research the treatment among people with mild COVID-19.

COVID-19 IN PREGNANCY Echoing guidance by the US CDC, England’s National Health Service (NHS England) on October 11 encouraged pregnant people to get vaccinated against SARS-CoV-2 and released data showing that, since July, nearly 1 in 5 of England’s most critically ill COVID-19 patients—those who required intensive care unit support including extracorporeal membrane oxygenation (ECMO)—have been unvaccinated pregnant women. Notably, of all women between the ages of 16 and 49 who have required ECMO in an intensive care unit, 32% of them have been pregnant, up from 6% at the beginning of the pandemic. NHS England is working to dispel misinformation and fears surrounding SARS-CoV-2 vaccines, pointing to safety data showing the shots are safe for pregnant individuals and their fetuses. According to data from the CDC, COVID-19 poses a significantly higher risk to pregnant people compared with non-pregnant people.

Several other recently released studies suggest that pregnant people with symptomatic COVID-19 are at a higher risk of emergency complications and other adverse perinatal and neonatal outcomes. A not-yet-peer-reviewed study presented over the weekend at the Anesthesiology 2021 Annual Meeting and a peer-reviewed study published October 10 in the Journal of Maternal-Fetal & Neonatal Medicine showed that pregnant people with COVID-19 who were symptomatic had an increased risk of giving birth in emergency circumstances and were more likely to have complications endangering their newborns, compared with those who had asymptomatic COVID-19 or who were not infected. Researchers writing in the American Journal of Obstetrics and Gynecology found that the recent surge of the Delta variant was associated with increased morbidity among pregnant people with COVID-19, particularly in underserved populations with low vaccine acceptance, prompting them to highlight the urgency of preventive measures during pregnancy, including vaccination. Additionally, experts attending the recent American Academy of Pediatrics (AAP) virtual meeting discussed neonatal outcomes, an apparent increase in preterm birth incidence among infected pregnant people compared with the 2019 incidence, as well as higher-than-expected maternal mortality among pregnant people testing positive at or around the day of delivery. All of the studies support emerging trends showing that COVID-19 can severely impact pregnant people and neonates, and provide evidence that vaccination is critically important for this population.

MENTAL HEALTH Prior to World Mental Health Day on October 10, a study published online on October 8 in The Lancet documented a grim and startling rise in cases of major depressive disorder (53.2 million new cases; 27.6% increase) and anxiety disorders (76.2 million new cases; 25.6% increase) globally from January 1, 2020 to January 29, 2021. The study was a systematic review of the prevalence of major depressive disorder and anxiety orders during the COVID-19 pandemic across various comprehensive sources, culminating in a meta-regression to estimate the rise in these 2 disorder types during the pandemic associated with COVID-19 impact indicators (e.g. mobility, daily SARS-CoV-2 infection rate). Impact indicators were found to be associated with increased prevalence of major depressive disorder and anxiety disorders, particularly among women and younger age groups.

The US CDC Morbidity and Mortality Weekly Report (MMWR) also published a similar study last week on national and state trends related to anxiety and depression during the pandemic. Findings noted that anxiety severity scores and depression severity scores increased from August 2020 to December 2020 before decreasing until June 2021.

RACIAL/ETHNIC DISPARITIES American Indian/Alaska Native (AI/AN), Black, and Latino individuals in the US have been disproportionately affected by the COVID-19 pandemic, with the disease causing more deaths by population size—both directly and indirectly—among these groups when compared with White or Asian populations. In a study published last week in the Annals of Internal Medicine, researchers reported that during the first 10 months of the pandemic (March-December 2020), an estimated 477,200 excess deaths occurred in the US than would have been expected based on 2019 data. Of these deaths, about 74% were directly attributable to COVID-19. After adjusting for age, overall excess deaths per 100,000 persons in 2020 were 2 to 3 times higher among AI/AN, Black, and Latino individuals compared with White and Asian individuals. Although the reasons for excess mortality are unknown, the researchers noted that “structural and social determinants of health with established and deep roots in racism”—including an increased risk of occupational exposure and lack of access to healthcare, possibly caused by fear during the pandemic—or misattribution of causes of death could have played roles.

The racial and ethnic disparities in COVID-19-related deaths spill over into the pandemic’s impacts on children. According to a modeling study published last week in Pediatrics, children of racial and ethnic minorities accounted for 65% of the more than 140,000 children who experienced orphanhood or lost a caregiver due to COVID-19 between April 2020 and June 2021. Compared to White children, AI/AN children were 4.5 times more likely to lose a caregiver, Black children were 2.4 times more likely, and Hispanic children were 1.8 times more likely. The highest burden of caregiver deaths due to COVID-19 occurred in states on the Southern US border, in the Southeast, and those with tribal areas. The researchers concluded there is an “urgent need” to provide affected children access to support services. An October 8 analysis from the Kaiser Family Foundation using CDC data shows that racial disparities in COVID-19 cases and death rates persist among Black, Hispanic, and AI/AN individuals, but data suggest the gap has recently narrowed for Black and Hispanic people. Notably, AI/AN individuals remain at disproportionate risk for COVID-19 disease and death, despite having the highest vaccination rate across racial/ethic groups. While the narrowing disparity in some groups could be due to increasing vaccination rates, other factors definitely play a role in ongoing disparities, and more research is needed to understand and address them.

AUSTRALIA On October 11, Australia began to emerge from its strict pandemic lockdown when New South Wales (NSW) began to allow fully vaccinated residents to return to restaurants, bars, hair salons, and gyms after nearly 4 months of restrictions. About 74% of NSW residents aged 16 and older are fully vaccinated, enabling the state—including Sydney, Australia’s most populous city—to ease its lockdown despite an ongoing outbreak. NSW State Premier Dominic Perrottet called it a “freedom day” and pledged to lead the nation out of the pandemic, but not without challenges. He warned that the number of new COVID-19 cases will rise following reopening, as virus-free Western Australia and Queensland and other so-called “zero COVID” countries in the Asia-Pacific region watch closely to see whether NSW can adapt to living with COVID-19.

ITALY’S GREEN PASS From October 15 through the end of 2021, Italian workers will be required to present a digital or printed “Green Pass” certificate upon entering their workplace, demonstrating that they have recovered from COVID-19 in the last six months, received a negative COVID-19 rapid antigen test result in the last 48 hours, received a negative COVID-19 molecular test result in the last 72 hours, or have been at least partially vaccinated. Workers who do not comply with the new mandate risk fines or suspension. Both civil and violent protests have broken out in response to the September 16 announcement regarding the new mandate in Italy, including reported clashes over the weekend between neo-fascists or other individuals associated with the far right and police. Some employees and policymakers are concerned that a rise in vaccinations may not occur, instead leading to worker shortages due to a lack of available tests.

The Green Pass already is required in Italy in order to access schools and universities, utilize public transport, participate in gatherings related to civil or religious ceremonies, visit medical facilities or long-term care facilities, access certain public gathering events or spaces, and pass through areas with higher COVID-19 risk—so-called “red” or “orange” zones. The Green Pass also is recognized by the European Union to help travelers avoid COVID-19 travel restrictions.